Medifast, Inc. (MED) is a Personal Products & Services company in the Consumer Cyclical sector, currently trading at $10.88. It has a SharesGrow Score of 51/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of MED = $23.40 (+115.1% from the current price, the stock appears undervalued). Analyst consensus target is MED = $12 (+10.3% upside).
Valuation: MED trades at a trailing Price-to-Earnings (P/E) of -6 (S&P 500 average ~25).
Financials: revenue is $386M, -37.6%/yr average growth. Net income is $19M (loss), growing at -373.9%/yr. Net profit margin is -4.8% (negative). Gross margin is 71.3% (+0 pp trend).
Balance sheet: total debt is $17M against $199M equity (Debt-to-Equity (D/E) ratio 0.08, conservative). Current ratio is 4.69 (strong liquidity). Debt-to-assets is 6.5%. Total assets: $257M.
Analyst outlook: 4 / 12 analysts rate MED as buy (33%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 15/100 (Fail), Past 75/100 (Partial), Health 100/100 (Pass), Moat 54/100 (Partial), Future 40/100 (Partial), Income 10/100 (Fail).
